VASAMED

VASAMED, Inc. designs, licenses, manufactures, and distributes noninvasive hemodynamic technologies for vascular, wound care, cardiovascular, and emergency medicine diagnostics. Its products include skin perfusion pressure systems and non-invasive cardiac output monitors. The company offers AcQtrac System that uses thoracic impedance cardiography to present a Cardiovasculogram waveform, which illustrates the mechanical function of the cardiovascular system, as well as used against congestive heart failure, hypertension, dystrophies requiring a pacemaker, and titrating therapies. It also offers SensiLase System, which allows physicians to assess micro-and macro circulation, as well as provides a combination of skin perfusion pressure and pulse volume recording tests that are useful in managing chronic wounds and other types of symptoms. The SensiLase Systems applications include assessing wound healing potential; monitoring pre/post-therapy, such as surgery and compression; arterial reconstruction planning and post-procedure monitoring; determining the optimal amputation level; amputation planning and post-procedure monitoring; and assisting in the diagnosis of peripheral arterial disease, critical limb ischemia, and other microcirculatory derangements. VASAMED, Inc. serves customers worldwide. The company has a patent license agreement with the Institute of Critical Care Medicine. It was formerly known as Optical Sensors Incorporated and changed its name to VASAMED, Inc. in June 2007. The company was founded in 1988 and is headquartered in Eden Prairie, Minnesota.